CSIRTS // UNIFIED SECURITY ADVISORY FEEDSYS ● ONLINE · POWERED BY INTELFUSIONS.COM

CVE-2026-47057: Vulnerability in Oracle Java SE (component: Scripting). Supported versions that are affected are Oracle Java SE: 8u491, 8u491-perf and 11.0.31. Easily exploitable vulnerability a

highCVSS 7.5CVE-2026-47057
Vulnerability in Oracle Java SE (component: Scripting). Supported versions that are affected are Oracle Java SE: 8u491, 8u491-perf and 11.0.31. Easily exploitable vulnerability allows unauthenticated attacker with network access via multiple protocols to compromise Oracle Java SE. Successful attacks of this vulnerability can result in unauthorized ability to cause a hang or frequently repeatable crash (complete DOS) of Oracle Java SE. Note: This vulnerability can be exploited by using APIs in the specified Component, e.g., through a web service which supplies data to the APIs. This vulnerability also applies to Java deployments, typically in clients running sandboxed Java Web Start applications or sandboxed Java applets, that load and run untrusted code (e.g., code that comes from the internet) and rely on the Java sandbox for security. CVSS 3.1 Base Score 7.5 (Availability impacts). CVSS Vector: (CVSS:3.1/AV:N/AC:L/PR:N/UI:N/S:U/C:N/I:N/A:H).

Details

Source
NVD Recent CVEs (US · database · site)
Severity
high — CVSS 7.5
Published
2026-07-21
Last updated
2026-07-23
Exploitation
Not in CISA KEV at last sync

Original advisory: https://nvd.nist.gov/vuln/detail/CVE-2026-47057

Exploitation outlook

EPSS (FIRST.org) estimates each CVE’s probability of exploitation in the next 30 days — here is the CSIRTS.com read on those numbers.

Referenced CVEs

CVECSIRTS overviewExternal
CVE-2026-47057coverage & exploitation statusNVD · CVE.org

Same CVEs, other sources

How other CERTs, PSIRTs and databases cover the vulnerabilities in this advisory.

Recent advisories for Oracle Java SE

A cluster of recent advisories against the same product widens the attack surface — attackers routinely chain freshly published CVEs on one product, so review these together.

More from NVD Recent CVEs